Research Paper Volume 15, Issue 21 pp 12136—12154
Multi-omics analysis reveals PUS1 triggered malignancy and correlated with immune infiltrates in NSCLC
Figure 6. High expression of PUS1 affects the prognosis of NSCLC. (A) Univariate Cox regression analysis showing the hazard ratios (HRs) with 95% confidence intervals (CIs) and P-values for 13 PUSs; (B) The OS Kaplan-Meier survival curves comparing the high and low expression of PUS1 in NSCLC based on Kaplan-Meier plotter (17 datasets); (C) The OS Kaplan-Meier survival curves comparing the high and low expression of PUS1 in NSCLC based on GSE15701 (N = 235), GSE68465 (N = 442), and GSE30219 (N = 293), in Kaplan-Meier plotter; (D) The Kaplan-Meier survival curves for FPS comparing high and low expression of PUS1 in NSCLC were based on GSE68465 and GSE30219 in Kaplan-Meier plotter; (E) The PPS Kaplan-Meier survival curves comparing the high and low expression of PUS1 in NSCLC based on GSE68465 and GSE30219 in Kaplan-Meier plotter.